EXABS-147-AML How Do We Overcome Resistance to Venetoclax

Kapil Saxena; Bing Z. Carter; Marina Konopleva

doi:10.1016/S2152-2650(22)00660-7

EXABS-147-AML How Do We Overcome Resistance to Venetoclax

Kapil Saxena, Bing Z. Carter, Marina Konopleva

Oncology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	S55-S57
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	22
DOIs	https://doi.org/10.1016/S2152-2650(22)00660-7
State	Published - Oct 2022

Keywords

AML
BCL-2
MCL1
TP53

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2152-2650(22)00660-7

Cite this

@article{7baedc3bb7574a2ea2c0182e39da166c,

title = "EXABS-147-AML How Do We Overcome Resistance to Venetoclax",

keywords = "AML, BCL-2, MCL1, TP53",

author = "Kapil Saxena and Carter, {Bing Z.} and Marina Konopleva",

year = "2022",

month = oct,

doi = "10.1016/S2152-2650(22)00660-7",

language = "English (US)",

volume = "22",

pages = "S55--S57",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Cancer Media Group",

}

TY - JOUR

T1 - EXABS-147-AML How Do We Overcome Resistance to Venetoclax

AU - Saxena, Kapil

AU - Carter, Bing Z.

AU - Konopleva, Marina

PY - 2022/10

Y1 - 2022/10

KW - AML

KW - BCL-2

KW - MCL1

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=85138160795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138160795&partnerID=8YFLogxK

U2 - 10.1016/S2152-2650(22)00660-7

DO - 10.1016/S2152-2650(22)00660-7

M3 - Article

C2 - 36164229

AN - SCOPUS:85138160795

SN - 2152-2650

VL - 22

SP - S55-S57

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

ER -

EXABS-147-AML How Do We Overcome Resistance to Venetoclax

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this